141 related articles for article (PubMed ID: 37562802)
1. Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
Gutsche R; Lowis C; Ziemons K; Kocher M; Ceccon G; Régio Brambilla C; Shah NJ; Langen KJ; Galldiks N; Isensee F; Lohmann P
J Nucl Med; 2023 Oct; 64(10):1594-1602. PubMed ID: 37562802
[TBL] [Abstract][Full Text] [Related]
2. A multi-label CNN model for the automatic detection and segmentation of gliomas using [
Rahimpour M; Boellaard R; Jentjens S; Deckers W; Goffin K; Koole M
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2441-2452. PubMed ID: 36933075
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
4. Fully automated analysis combining [
Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
Bashir A; Brennum J; Broholm H; Law I
J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154
[TBL] [Abstract][Full Text] [Related]
6. Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
Blanc-Durand P; Van Der Gucht A; Schaefer N; Itti E; Prior JO
PLoS One; 2018; 13(4):e0195798. PubMed ID: 29652908
[TBL] [Abstract][Full Text] [Related]
7. O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.
Hutterer M; Nowosielski M; Putzer D; Waitz D; Tinkhauser G; Kostron H; Muigg A; Virgolini IJ; Staffen W; Trinka E; Gotwald T; Jacobs AH; Stockhammer G
J Nucl Med; 2011 Jun; 52(6):856-64. PubMed ID: 21622893
[TBL] [Abstract][Full Text] [Related]
8. Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.
Galldiks N; Unterrainer M; Judov N; Stoffels G; Rapp M; Lohmann P; Vettermann F; Dunkl V; Suchorska B; Tonn JC; Kreth FW; Fink GR; Bartenstein P; Langen KJ; Albert NL
Neuro Oncol; 2019 Oct; 21(10):1331-1338. PubMed ID: 31077276
[TBL] [Abstract][Full Text] [Related]
9. A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text]F]FDG PET/CT.
Nikulin P; Zschaeck S; Maus J; Cegla P; Lombardo E; Furth C; Kaźmierska J; Rogasch JMM; Holzgreve A; Albert NL; Ferentinos K; Strouthos I; Hajiyianni M; Marschner SN; Belka C; Landry G; Cholewinski W; Kotzerke J; Hofheinz F; van den Hoff J
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2751-2766. PubMed ID: 37079128
[TBL] [Abstract][Full Text] [Related]
10. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
11. Early Treatment Response Assessment Using
Ceccon G; Lohmann P; Werner JM; Tscherpel C; Dunkl V; Stoffels G; Rosen J; Rapp M; Sabel M; Herrlinger U; Schäfer N; Shah NJ; Fink GR; Langen KJ; Galldiks N
J Nucl Med; 2021 Jul; 62(7):918-925. PubMed ID: 33158907
[TBL] [Abstract][Full Text] [Related]
12. Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
Hutterer M; Ebner Y; Riemenschneider MJ; Willuweit A; McCoy M; Egger B; Schröder M; Wendl C; Hellwig D; Grosse J; Menhart K; Proescholdt M; Fritsch B; Urbach H; Stockhammer G; Roelcke U; Galldiks N; Meyer PT; Langen KJ; Hau P; Trinka E
J Nucl Med; 2017 Jan; 58(1):129-137. PubMed ID: 27469356
[TBL] [Abstract][Full Text] [Related]
13. Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
Galldiks N; Rapp M; Stoffels G; Fink GR; Shah NJ; Coenen HH; Sabel M; Langen KJ
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):22-33. PubMed ID: 23053325
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of
Rosen J; Ceccon G; Bauer EK; Werner JM; Tscherpel C; Dunkl V; Rapp M; Sabel M; Herrlinger U; Heinzel A; Schäfer N; Ruge M; Goldbrunner R; Stoffels G; Kabbasch C; Fink GR; Langen KJ; Galldiks N
J Nucl Med; 2022 Nov; 63(11):1677-1682. PubMed ID: 35422443
[TBL] [Abstract][Full Text] [Related]
15. Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.
Müller M; Winz O; Gutsche R; Leijenaar RTH; Kocher M; Lerche C; Filss CP; Stoffels G; Steidl E; Hattingen E; Steinbach JP; Maurer GD; Heinzel A; Galldiks N; Mottaghy FM; Langen KJ; Lohmann P
J Neurooncol; 2022 Sep; 159(3):519-529. PubMed ID: 35852737
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
[TBL] [Abstract][Full Text] [Related]
17. Impact of
Brendle C; Maier C; Bender B; Schittenhelm J; Paulsen F; Renovanz M; Roder C; Castaneda-Vega S; Tabatabai G; Ernemann U; Fougère C
J Nucl Med; 2022 Apr; 63(4):522-527. PubMed ID: 34353870
[TBL] [Abstract][Full Text] [Related]
18. Flare Phenomenon in
Filss CP; Schmitz AK; Stoffels G; Stegmayr C; Lohmann P; Werner JM; Sabel M; Rapp M; Goldbrunner R; Neumaier B; Mottaghy FM; Shah NJ; Fink GR; Galldiks N; Langen KJ
J Nucl Med; 2020 Sep; 61(9):1294-1299. PubMed ID: 32005771
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy Target Volume Definition in Newly Diagnosed High-Grade Glioma Using 18F-FET PET Imaging and Multiparametric MRI: An Inter Observer Agreement Study.
Dissaux B; Mazouz Fatmi D; Ognard J; Allard B; Keromnes N; Latreche A; Lepeuve A; Schick U; Bourbonne V; Ben Salem D; Dissaux G; Querellou S
Tomography; 2022 Aug; 8(4):2030-2041. PubMed ID: 36006068
[TBL] [Abstract][Full Text] [Related]
20. Treatment-Related Uptake of
Geisler S; Stegmayr C; Niemitz N; Lohmann P; Rapp M; Stoffels G; Willuweit A; Galldiks N; Filss C; Sabel MC; Coenen HH; Shah NJ; Langen KJ
J Nucl Med; 2019 Oct; 60(10):1373-1379. PubMed ID: 30850492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
